Peter Altman Insider Trades & Stock Holdings

President and CEO · BioCardia, Inc. · Latest filing Jun 18, 2026

Peter Altman, President and CEO at BioCardia, Inc. has 3 Form 4 trades on file since Jun 17, 2026. Open-market activity: 3 purchases ($2.81K) and 0 sales ($0), net +$2.81K. Latest filing: acquired 800 shares of $BCDA on Jun 18, 2026 at $0.96.

Trades on file

3

Open-market bought

$2.81K

Open-market sold

$0

Net open-market

+$2.81K

Latest filing

Jun 18, 2026

All insider trades by Peter Altman

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 18, 2026	$BCDA	Buy (Open-market buy)	800	$0.96	$768			+12.4%	-7.2%		President and CEO		Read
Jun 18, 2026	$BCDA	Buy (Open-market buy)	800	$0.96	$768			+12.4%	-7.2%		President and CEO		Read
Jun 17, 2026	$BCDA	Buy (Open-market buy)	1.50K	$0.85	$1.27K			+11.6%	-12.6%		President and CEO		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Peter Altman traded

• $BCDA

Frequently asked questions

Has Peter Altman been buying or selling stock?

Peter Altman has 3 open-market purchases and 0 open-market sales on file, net +$2.81K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Peter Altman's latest insider trade?

acquired 800 shares of $BCDA on Jun 18, 2026 at $0.96.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.